IECM
IDXX icon

Intrinsic Edge Capital Management’s Idexx Laboratories IDXX Stock Holding History

Intrinsic Edge Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,600
Closed -$1.31M – 164
2023
Q2 		$1.31M Buy
+2,600
New +$1.25M 0.09% 147

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Intrinsic Edge Capital Management's IDXX Position: Q3 2023 in Review

Intrinsic Edge Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 2,600 shares — an estimated $1.31M sold.

Intrinsic Edge Capital Management first reported a position in IDXX in Q2 2023 and held it in 1 quarter. The position peaked at $1.31M in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Intrinsic Edge Capital Management reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 2,600 Idexx Laboratories shares in Q3 2023, an estimated $1.31M.
  • Intrinsic Edge Capital Management first reported a position in Idexx Laboratories in Q2 2023 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's Idexx Laboratories position peaked at $1.31M in Q2 2023.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.